Cirrhotic cardiomyopathy and portal hypertension: addressing the full disease spectrum in heart-liver co-management [0.03%]
肝心联合治疗中 cirrhosis 心肌病和门脉高压的诊治谱扩大问题探讨
Madeleine Gill,Geoffrey W McCaughan,Anoop N Koshy et al.
Madeleine Gill et al.
Upfront medical or surgical treatment in Crohn's disease - Authors' reply [0.03%]
克罗恩病的初期医学或手术治疗——作者回复
Lotte Oldenburg,Anouck E G Haanappel,Geert R DHaens et al.
Lotte Oldenburg et al.
Nurulamin M Noor,Phillip R Fleshner,Gil Y Melmed et al.
Nurulamin M Noor et al.
Aaron S Bancil,Edward M Giles,Jessica Fitzpatrick
Aaron S Bancil
Cyclic exclusive enteral nutrition in paediatric Crohn's disease - Authors' reply [0.03%]
儿童克罗恩病周期性肠外营养治疗——作者的回复
Bénédicte Pigneur,Frank M Ruemmele
Bénédicte Pigneur
Breaking the cycle: from documenting data scarcity to enabling global IBD research [0.03%]
打破循环:从记录数据匮乏到实现全球炎症性肠病研究
Mohammed Nabil Quraishi,Badr Al-Bawardy,Rupa Banerjee et al.
Mohammed Nabil Quraishi et al.
Alaska Native peoples and colorectal cancer: opportunities for research and prevention [0.03%]
阿拉斯加土著居民和结直肠癌:研究与预防的机会
Diana Redwood,LaRita Laktonen-Ward,Elena Roik
Diana Redwood
A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV? [0.03%]
变幻中的HIV治疗格局:Lenacapavir对HBV感染者意味着什么?
Philippa C Matthews,Marion Delphin,Motswedi Anderson et al.
Philippa C Matthews et al.
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology